Marine Organisms with Anti-Diabetes Properties

Abstract

Diabetes is a chronic degenerative metabolic disease with high morbidity and mortality rates caused by its complications. In recent years, there has been a growing interest in looking for new bioactive compounds to treat this disease, including metabolites of marine origin. Several aquatic organisms have been screened to evaluate their possible anti-diabetes activities, such as bacteria, microalgae, macroalgae, seagrasses, sponges, corals, sea anemones, fish, salmon skin, a shark fusion protein as well as fish and shellfish wastes. Both in vitro and in vivo screenings have been used to test anti-hyperglycemic and anti-diabetic activities of marine organisms. This review summarizes recent discoveries in anti-diabetes properties of several marine organisms as well as marine wastes, existing patents and possible future research directions in this field.

Contributors

Patrizia Russo: Role: Academic Editor

Journal

Journal ID (nlm-ta): Mar Drugs

Journal ID (iso-abbrev): Mar Drugs

Journal ID (publisher-id): marinedrugs

Title: Marine Drugs

Publisher: MDPI

ISSN (Electronic): 1660-3397

Publication date (Electronic): 01 December 2016

Publication date Collection: December 2016

Volume: 14

Issue: 12

Affiliations

Department of Integrative Marine Ecology, Stazione Zoologica Anton Dohrn, 80121 Naples, Italy; adrianna.ianora@ 123456szn.it

Author notes

[* ]Correspondence: chiara.lauritano@ 123456szn.it ; Tel.: [phone]

Article

Publisher ID: marinedrugs-14-00220

DOI: 10.3390/md14120220

PMC ID: 5192457

PubMed ID: 27916864

Copyright statement: © 2016 by the authors; licensee MDPI, Basel, Switzerland.

License:

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license ( http://creativecommons.org/licenses/by/4.0/).

Categories

Subject: Review